Remedium Therapeutics Private Limited
Remedium Therapeutics Private Limited is a Private Non-govt company company incorporated in 2020 and based in Tamil Nadu, India. It was founded by Apparsundaram and Jammi. Remedium Therapeutics Private Limited operates in Chemical preparations of a kind used in textile / paper / leather industry, manu (NIC 24297) with authorized capital of ₹50.00 L and paid-up capital of ₹31.73 L. For 2023-24, the company reported revenue of ₹18.19 L and a net loss of ₹37.23 L. The board has 2 active directors. RegisterKaro's provisional Compliance Health Score for the company is 100/100 (grade A), based on 4 of 9 signals — full scoring is pending extraction of the company's MCA filing history.
Quick facts
Directors
2 activeMCA Filings
Locked| Form | FY | Filed | Due | Delay | Status |
|---|---|---|---|---|---|
| AOC-4 | FY2024-25 | 30 Oct 2024 | 30 Oct 2024 | 0d | filed |
| MGT-7 | FY2024-25 | 21 Nov 2024 | 29 Nov 2024 | 0d | filed |
| AOC-4 | FY2023-24 | 30 Oct 2023 | 30 Oct 2023 | 0d | filed |
| MGT-7 | FY2023-24 | 25 Nov 2023 | 29 Nov 2023 | 0d | filed |
| AOC-4 | FY2022-23 | 30 Oct 2022 | 30 Oct 2022 | 0d | filed |
| MGT-7 | FY2022-23 | 25 Nov 2022 | 29 Nov 2022 | 0d | filed |
Full MCA filing history for Remedium Therapeutics Private Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Charges
Locked| Charge ID | Holder | Amount | Created | Status |
|---|---|---|---|---|
| 294439350 | State Bank of India(Bank) | ₹22.00 Cr | 12 Mar 2022 | Open |
| 578799481 | HDFC Bank Ltd(Bank) | ₹11.56 Cr | 12 Mar 2019 | Open |
| 206134326 | Kotak Mahindra Bank Ltd(Bank) | ₹17.33 Cr | 19 Sep 2020 | Open |
| 392276701 | State Bank of India(Bank) | ₹8.81 Cr | 04 Jul 2019 | Open |
| 552586848 | Axis Bank Ltd(Bank) | ₹19.25 Cr | 04 Jul 2021 | Open |
| 522773159 | State Bank of India(Bank) | ₹2.49 Cr | 19 Sep 2022 | Open |
Charge IDs, lenders & amounts for Remedium Therapeutics Private Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Financial Performance
MCA| FY | Revenue | PAT | Net Worth | Total Assets | Employees |
|---|---|---|---|---|---|
| 2023-24 | — | ||||
| 2022-23 | — | ||||
| 2021-22 | — | ||||
| 2020-21 | — |
Detailed Financials
4 FYs| Line item | 2023-24 | 2022-23 | 2021-22 | 2020-21 |
|---|---|---|---|---|
| Income statement | ||||
| Revenue from operations | ||||
| Other income | ||||
| Total income | ||||
| Total expenses | ||||
| Profit before tax | ||||
| Profit / (Loss) after tax | ||||
| Balance sheet | ||||
| Equity / Net worth | ||||
| Borrowings | ||||
| Current liabilities | ||||
| Total liabilities | ||||
| Current assets | ||||
| Cash & equivalents | ||||
| Total assets | ||||
| Employees | — | — | — | — |
Cash-flow statement renders when the AOC-4 XBRL Cash Flow context is parsed during the extract phase.
Compounded Annual Growth Rate
| Metric | Latest value | 1Y CAGR | 3Y CAGR | 5Y CAGR |
|---|---|---|---|---|
| Revenue2023-24 | +549.0% | — | — | |
| Profit after Tax2023-24 | — | — | — | |
| Net Worth2023-24 | -81.0% | -63.0% | — |
Financial Ratios
| FY | Revenue | PAT | PAT margin | Rev growth | ROE | ROA | D/E | Rev/emp |
|---|---|---|---|---|---|---|---|---|
| 2020-21 | — | — | -3.93% | -3.89% | 1.01 | |||
| 2021-22 | -251.33% | — | -22.84% | -21.53% | 1.06 | |||
| 2022-23 | -1896.61% | -78.78% | -57.65% | -35.92% | 1.60 | |||
| 2023-24 | -204.69% | +429.27% | -49.09% | -25.33% | 1.94 |
Cap Table & Shareholding
Locked| Category | Shareholders | Shares held | % |
|---|---|---|---|
| Promoters | 2 | 74,74,823 | 73.40% |
| Institutional Investors | 2 | 6,15,630 | 6.05% |
| Public & Others | 9 | 20,93,267 | 20.56% |
Promoter, institutional & public holding for Remedium Therapeutics Private Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Peer Benchmark
136 peersTop 10 in Chemical preparations of a kind used in textile / paper / leather industry, manu
by healthView all ›Events & timeline
3External data sources
7 plannedGSTIN Registrations
Per-state GSTINs + GSTR-1/3B filing cadence + turnover bracket. PAN-keyed scrape.
MSME Payment Delays
Half-yearly disclosure of payments delayed beyond 45 days to MSME suppliers.
Related Party Transactions
Counterparty, nature, transaction value. Inter-company loans, sales, royalty.
Credit Ratings
Long-term + short-term ratings, with rationale on rating actions.
Trademarks
Applied, registered, opposed. Class numbers + status.
Patents
Applications and grants. Inventor names + filing dates.
Legal Cases
Ongoing + past litigations the entity is party to.
Each source is wired as a separate ingestion adapter behind the scraper. Live status flips per CIN as records land.